{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:42:01Z","timestamp":1761597721871},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T00:00:00Z","timestamp":1465948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.tube.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T22:35:26Z","timestamp":1466202926000},"page":"S21-S25","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["Epidemiologic studies and novel clinical research approaches that impact TB vaccine development"],"prefix":"10.1016","volume":"99","author":[{"given":"Thomas G.","family":"Evans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin J.","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Penn-Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dereck R.","family":"Tait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hatherill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2016.05.008_bib1","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis","volume":"375","author":"Kaufmann","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2016.05.008_bib2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.tube.2016.05.008_bib3","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.05.008_bib4","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B-ESAT-6 adjuvanted with IC31(R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.05.008_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1164\/rccm.201206-1134OC","article-title":"Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents","volume":"186","author":"Machingaidze","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2016.05.008_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2016.05.008_bib7","series-title":"ClinicalTrials.gov [Internet]","article-title":"Study to evaluate the efficacy of GlaxoSmithKline (GSK) biologicals' candidate tuberculosis (TB) vaccine in adults","author":"GlaxoSmithKline Aeras","year":"2000"},{"key":"10.1016\/j.tube.2016.05.008_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/MMBR.00021-14","article-title":"Tuberculosis vaccines and prevention of infection","volume":"78","author":"Hawn","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.tube.2016.05.008_bib9","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.tube.2016.05.008_bib10","doi-asserted-by":"crossref","first-page":"e17984","DOI":"10.1371\/journal.pone.0017984","article-title":"The tuberculin skin test versus QuantiFERON TB Gold(R) in predicting tuberculosis disease in an adolescent cohort study in South Africa","volume":"6","author":"Mahomed","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.05.008_bib11","first-page":"471","article-title":"The instability of the tuberculin reaction. Observations on dispensary patients with special reference to the existence of demonstrable tuberculous lesions and the degree of exposure to tubercle bacilli","volume":"42","author":"Dahlstrom","year":"1940","journal-title":"Am Rev Tuberc Pulm Dis"},{"key":"10.1016\/j.tube.2016.05.008_bib12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.5588\/ijtld.13.0834","article-title":"Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis","volume":"18","author":"Dharmadhikari","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2016.05.008_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","article-title":"The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents","volume":"191","author":"Andrews","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2016.05.008_bib14","series-title":"ClinicalTrials.gov [Internet]","article-title":"A\u00a0randomized, placebo controlled, partially blinded phase II study to evaluate safety, immunogenicity, and prevention of infection with Mycobacterium Tuberculosis of AERAS-404 and BCG revaccination in healthy adolescents (040\u2013404)","author":"Aeras","year":"2000"},{"key":"10.1016\/j.tube.2016.05.008_bib15","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/ciu186","article-title":"The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study","volume":"58","author":"Marx","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2016.05.008_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.tube.2016.05.008_bib17","doi-asserted-by":"crossref","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","article-title":"A\u00a0defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tube.2016.05.008_bib18","doi-asserted-by":"crossref","first-page":"e23826","DOI":"10.1371\/journal.pone.0023826","article-title":"Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.05.008_bib19","first-page":"380","article-title":"What is the role of clinical trials for the treatment of tuberculosis and what are the alternatives?","volume":"14","author":"Nunn","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2016.05.008_bib20","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/infdis\/jiu574","article-title":"Recurrence due to relapse or reinfection with Mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-up","volume":"211","author":"Guerra-Assun\u00e7\u00e3o","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2016.05.008_bib21","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"Knight","year":"2014","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.tube.2016.05.008_bib22","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1016\/j.vaccine.2015.03.070","article-title":"A\u00a0double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants","volume":"33","author":"Tameris","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.05.008_bib23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1586\/14760584.2014.929947","article-title":"Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future?","volume":"13","author":"Smaill","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2016.05.008_bib24","doi-asserted-by":"crossref","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","article-title":"A\u00a0human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tube.2016.05.008_bib25","doi-asserted-by":"crossref","first-page":"e0135009","DOI":"10.1371\/journal.pone.0135009","article-title":"AdHu5Ag85A respiratory mucosal boost immunization enhances protection against pulmonary tuberculosis in BCG-primed non-human primates","volume":"10","author":"Jeyanathan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.05.008_bib26","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/S0140-6736(15)60553-0","article-title":"Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"385","author":"Zhu","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2016.05.008_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(14)71085-0","article-title":"Latent tuberculosis infection in rural areas of China: baseline results of a population-based multicenter prospective study","volume":"15","author":"Gao","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2016.05.008_bib28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S1473-3099(15)00251-0","article-title":"Differences in BCG vaccination and tuberculin skin-test positivity - Authors' reply","volume":"15","author":"Gao","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2016.05.008_bib29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1183\/09031936.00145714","article-title":"High tuberculosis burden among people living with HIV in southern Mozambique","volume":"45","author":"Garcia-Basteiro","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2016.05.008_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/INF.0000000000000710","article-title":"Incidence of tuberculosis among young children in rural Mozambique","volume":"34","author":"Lopez-Varela","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tube.2016.05.008_bib31","series-title":"Global tuberculosis report","author":"World Health Organization (WHO)","year":"2015"},{"key":"10.1016\/j.tube.2016.05.008_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(14)60069-6","article-title":"Mozambique faces challenges in the fight against tuberculosis","volume":"383","author":"Garcia-Basteiro","year":"2014","journal-title":"Lancet"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297921630186X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297921630186X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T05:51:08Z","timestamp":1536645068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147297921630186X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":32,"alternative-id":["S147297921630186X"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2016.05.008","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiologic studies and novel clinical research approaches that impact TB vaccine development","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}